Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets

HAYWARD, Calif., Aug. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), today announced a Settlement Agreement (the "Contract Settlement Agreement") to resolve a contract dispute relating to an agreeme... Biopharmaceuticals, Litigation Impax Laboratories, Opana ER, Oxymorphone, Endo International, Penwest
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news